Abstract
Hyper-pigmentation causes skin darkness and medical disorders, such as post-inflammatory melanoderma and melasma. Therefore, the development of anti-melanogenic agents is important for treating these conditions and for cosmetic production. In our previous paper, we demonstrated that the anti-diabetic drug voglibose, a valiolamine derivative, is a potent anti-melanogenic agent. In addition, we proposed an alternative screening strategy to identify valiolamine derivatives with high skin permeability that act as anti-melanogenic agents when applied topically. In this study, we synthesized several valiolamine derivatives with enhanced lipophilicity and examined their inhibitory effects in a human skin model. N-(2-hydroxycyclohexyl)valiolamine (HV) possesses a stronger inhibitory effect on melanin production than voglibose in a human skin model, suggesting that HV is a more potent anti-melanogenic agent for the skin. © 2014 by the authors; licensee MDPI, Basel, Switzerland.
Author supplied keywords
Cite
CITATION STYLE
Bin, B. H., Joo, Y. H., Lee, A. Y., Shin, S. S., Cho, E. G., & Lee, T. R. (2014). Novel inhibitory effect of N-(2-Hydroxycyclohexyl)valiolamine on melanin production in a human skin model. International Journal of Molecular Sciences, 15(7), 12188–12195. https://doi.org/10.3390/ijms150712188
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.